What perturbs me slightly is that it seems to me that there has been a significant change in direction here. Forgive me if I am a little naive but when I invested in CDX we were going to compete for market share with the Pulse with Omron etc with OTC with our central blood pressure advantage.Then we were going to produce the band again with CBP to compete with Apple etc. Now we seem to be transitioning into something entirely different talking about “software as a medical device “ and no mention of the band. Q where are you??
Forgive my naivety as someone who paid their bills with cheques until a couple of years ago, could someone give me a heads up as were we are headed here. It all seems rather positive despite the fact that the shares price needs something to cure its erectile disjunction!! Drooping at the critical moment.
Cheers dig
Add to My Watchlist
What is My Watchlist?
